CryoPort Expands Biotech Reach

Company Initiates Several Pilot Programs for Shipping Stem Cells and Biologics Globally

LAKE FOREST, CA -- (MARKET WIRE) -- 03/25/08 -- CryoPort, Inc. (OTCBB: CYRX) today announced that it has a successfully completed several shipments of stem cells and other biological materials for a number of potential biotech customers utilizing the CryoPort Express(TM) Shipper.

In the next two to three weeks additional shipments will be made to a number of different global locations including Peru, Australia and Canada. These shipments are all part of pilot programs to showcase the ease of use, the stringent temperature control and strength of the CryoPort Express(TM) Shippers.

Peter Berry, CEO of CryoPort, stated, "We continue to make strides in our introduction of the CryoPort Express(TM) Shipper. Our pilot programs continue to expand and add potential clients that we believe over the long term will become ongoing users of the CryoPort Express(TM) Shipper."

To be added to CryoPort's investor list, please email: edward@carpedminc.com

About CryoPort, Inc.

CryoPort (www.cryoport.com) develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

"SAFE HARBOR"

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact:
Stuart Fine
Carpe DM, Inc.
908-469-1788

Released March 25, 2008